RocketTickers

Aquestive Therapeutics Reports Positive Topline Data from Part 1

Long
NASDAQ:AQST   Aquestive Therapeutics, Inc.
AQST: Aquestive Therapeutics, Inc.
2022-02-25 07:00:00
Aquestive Therapeutics Reports Positive Topline Data from Part 1 of EPIPHAST Trial Evaluating AQST-109 Epinephrine
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.